Brussels, 25/08/2005 (Agence Europe) -The European Commission has authorised plans by Johnson & Johnson (J&J) to purchase its fellow American company and competitor Guidant, a company which specialises in cardiovascular devices. This operation, which has been valued at 19 billion EUR, required commitments from both parties, which will sell assets related to J&J's manoeuvrable guides within the European Economic Area and all of Guidant's endovascular and heart surgery (Endoscopic Vein...